ESTECH Launches AFfirm(TM), First Cardiac Surgery Product Indicated For Use In The Treatment Of Atrial Fibrillation

SAN RAMON, Calif.--(BUSINESS WIRE)--June 1, 2006--ESTECH announced today market launch of AFfirm(TM), an Atrial Fibrillation (AF) conduction block verification probe and the latest product innovation in ESTECH’s drive to set a new standard in Atrial Fibrillation treatments.

MORE ON THIS TOPIC